Physician profile
Kyle E Fetterolf
NPI 1477529501
$3,581.71
in general payments reported to CMS, 2019-2025
19 companies · $1,314 in 2025
The $1,314 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $580 · 2022: $854 · 2023: $401 · 2024: $433 · 2025: $1,314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,143 · Education: $4.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,142.71 |
| Education | $4.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $764.73 | 2021-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $545.81 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $516.84 | 2021-2024 | Breztri, Airsupra |
| Sumitomo Pharma America, INC. | $395.06 | 2025 | Gemtesa |
| Alexion Pharmaceuticals, INC. | $260.00 | 2021-2022 | |
| Novo Nordisk INC | $125.00 | 2022 | |
| Phathom Pharmaceuticals, INC. | $124.74 | 2024 | Voquezna |
| Axsome Therapeutics, INC. | $115.56 | 2023 | Sunosi |
| Biocryst US Sales Co., LLC | $111.74 | 2022 | |
| Neurelis, INC. | $106.97 | 2022 | |
| Glaxosmithkline, LLC. | $96.78 | 2023 | |
| Astellas Pharma US INC | $94.26 | 2025 | Xtandi |
| Pfizer INC. | $82.31 | 2021-2025 | |
| Telix Pharmaceuticals | $67.90 | 2025 | Illuccix |
| Janssen Biotech, INC. | $58.47 | 2025 | Erleada |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $40.24 | 2025 | |
| Teleflex LLC | $33.45 | 2025 | Barrigel |
| Boston Scientific Corporation | $26.76 | 2025 | Axonics |
| Bioxcel Therapeutics, INC. | $15.09 | 2023 | Igalmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Fetterolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.